Emcure Pharmaceuticals Ltd. · EMCURE

Every Emcure Pharmaceuticals Ltd. result whose ten-session window has closed, judged against the last read made before it. Sector index NIFTY HEALTHCARE INDEX. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →

9results judged

0read right

0read wrong

0flat / no call

9unread

44%beat the market

-0.6%avg vs market, 10d

3.6%avg move, T+1

How the reads on it fared

Read	Judged	Right	Wrong	Flat	Hit rate	Avg vs mkt
unread	9	0	0	0	—	-0.6%

A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.

Reading the rows

T+1: the share's move on the first session after the result, from the close before it
T+10: the move over ten sessions, same base
vs market: T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
Run-up: the share's move in the thirty sessions before the result
Result: reported profit growth against the company's own last four quarters: good, in line, bad

Each result

9 judged · newest first · open one

Result	Read	Outcome	T+1	T+10	vs market	Run-up	Result	Why
6 Aug Q1FY27	—	unread	+3.0%	-3.8%	-2.2%	+3%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. Went into the result within 3% of its 52-week high. 2 more	›
5 May Q4FY26	—	unread	-1.5%	+2.6%	+4.1%	+15%	no figures	Its sector moved +5.0% over the window. No reported figures on file for this quarter, so the result itself could not be judged. 2 more	›
4 Feb Q3FY26	—	unread	-1.3%	-6.6%	-5.4%	+11%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. Went into the result within 3% of its 52-week high. 2 more	›
11 Nov Q2FY26	—	unread	+0.7%	+2.0%	+0.0%	+3%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. Volume ran 3.0x its prior month in the fortnight before. 2 more	›
7 Aug Q1FY26	—	unread	-0.8%	+6.6%	+5.1%	+6%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. 7 sector peers reported the same week; the sector read may already have been set. 1 more	›
22 May Q4FY25	—	unread	+20.2%	+13.7%	+12.1%	+18%	no figures	Ran up 18% in the 30 sessions before the result — a good number had little left to reward. No reported figures on file for this quarter, so the result itself could not be judged. 2 more	›
6 Feb Q3FY25	—	unread	-3.0%	-20.6%	-17.3%	-12%	no figures	The market itself moved -3.3% over the same ten sessions; the raw move is mostly tide. Its sector moved -5.5% over the window. 4 more	›
8 Nov Q2FY25	—	unread	-0.4%	-8.9%	-9.0%	-2%	no figures	No reported figures on file for this quarter, so the result itself could not be judged. Announced during market hours, so the reaction session is the announcement day itself. 2 more	›
13 Aug Q1FY25	—	unread	+1.8%	+11.2%	+7.0%	—	no figures	The market itself moved +4.2% over the same ten sessions; the raw move is mostly tide. No reported figures on file for this quarter, so the result itself could not be judged. 3 more	›